glp 1 dangers GLP-1 Medications: Everything You Need to Know Your guide to GLP-1 side

De Leon et al compared genes induced by exendin to those expressed following partial pancreatectomy and found a set that included multiple Reg genes as well as fragilis and serpin b1a (21)

GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for the management of type 2 diabetes mellitus and, in some cases, for weight management in adults with obesity or overweight with weight-related comorbidities

A Gamma model was suitable for semaglutide-related SSIBs, and a Weibull model described the latency of dulaglutide-related SSIBs well

Secondary analyses of the MAESTRO-NASH trial suggest that resmetirom retains efficacy in patients concomitantly using GLP-1 RAs, supporting the feasibility of combination approaches [71]